Replies to post #12708 on GTC Biotherapeutics (fka GTCB)

[DewDiligence]

Re: Size of CABG/HR market

Dr. Cox said on today’s webcast that CABG/HR is a $100-150M market opportunity in the US, which is consistent with my $100-200M estimate in #msg-30546734.

I’ll defer to Dr. Cox and lower the upper bound of the range to $150M.